GO:0005689 U12-type spliceosomal complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005689 (U12-type spliceosomal complex) is the cellular machinery that removes rare non-canonical introns with AT-AC termini and other atypical splice sites.
• The minor spliceosome is evolutionarily distinct from the major U2-type spliceosome and uses U11, U12, U4atac, and U6atac snRNPs instead of U1, U2, U4, and U6.
• Cryo-EM structures have revealed the stepwise assembly and catalytic core of the human minor spliceosome, including how U12-type introns are engaged.
• U12-type introns are rare but highly conserved, and their mis-splicing is linked to developmental disorders and cancer.
• RNU4ATAC mutations cause severe developmental diseases such as microcephalic osteodysplastic primordial dwarfism type I (MOPD I).
• Studying U12-type splicing requires specialized methods including RNA-seq, cryo-EM, and CRISPR-based models of minor spliceosome components.
Description
The U12-type spliceosomal complex (GO:0005689) is a cellular component that catalyzes the removal of a minor class of introns from messenger RNA primary transcripts. These introns are characterized by atypical AT-AC terminal dinucleotides and other non-canonical splice site signals, and they are spliced by a dedicated machinery known as the minor spliceosome. The entire splice site signal, not just the terminal dinucleotides, determines whether an intron is recognized by the U12-type or the major U2-type spliceosome. This complex is essential for accurate gene expression in eukaryotes, and its dysfunction has been associated with human disease. Unlike the major spliceosome, which consists of U1, U2, U4, U6, and U5 snRNPs, the minor spliceosome uses U11, U12, U4atac, and U6atac snRNPs together with a shared U5 snRNP. Recent cryo-EM studies have provided near-atomic resolution structures of the fully assembled human minor spliceosome, revealing how U12-type introns are recognized and positioned for catalysis. These structural insights are critical for understanding the molecular basis of U12-type splicing and for interpreting disease-associated mutations in minor spliceosome components. U12-type introns are rare, comprising less than 1% of all introns in some organisms, but they are highly conserved across evolution. Their splicing is not limited by the abundance of minor snRNPs, suggesting that other regulatory mechanisms control U12-type intron removal. In plants, U12-type splicing factors such as U11/U12-31K are essential for development, highlighting the biological importance of this complex beyond humans. This article provides a comprehensive overview of the U12-type spliceosomal complex, its components, assembly, molecular mechanism, and its relevance to disease and research.
U12-type spliceosomal complex At A Glance
| GO ID | GO:0005689 |
|---|---|
| GO term | U12-type spliceosomal complex |
| Ontology | cellular_component |
| Synonym | AT-AC spliceosomal complex, minor spliceosomal complex, minor (U12-type) spliceosomal complex |
| Major function | Splicing of U12-type introns with atypical AT-AC termini and other non-canonical introns |
| Composition | U11, U12, U4atac, U6atac, and U5 snRNPs plus associated proteins |
| Evolutionary conservation | Present in animals, plants, and some protists; U12 introns are rare but conserved |
| Disease relevance | Mutations in RNU4ATAC cause MOPD I and related developmental disorders |
What Is GO:0005689?
The U12-type spliceosomal complex is any spliceosomal complex that forms during the splicing of a messenger RNA primary transcript to excise an intron. The series of U12-type spliceosomal complexes is involved in the splicing of the majority of introns that contain atypical AT-AC terminal dinucleotides, as well as other non-canonical introns. The entire splice site signal, not just the terminal dinucleotides, is involved in determining which spliceosome utilizes the site. This complex is also known as the AT-AC spliceosomal complex or the minor spliceosomal complex.
Why Is U12-type spliceosomal complex Important in Cell Biology?
The U12-type spliceosomal complex is essential for the accurate expression of genes containing U12-type introns, which are found in critical genes involved in DNA replication, repair, and cell cycle control. Dysregulation of minor splicing has been linked to developmental disorders and cancer, making this complex a subject of intense research. Understanding its structure and mechanism provides a foundation for interpreting disease-causing mutations and for developing therapeutic strategies.
• U12-type introns are present in essential genes, and their mis-splicing can disrupt gene expression.
• The minor spliceosome is structurally and functionally distinct from the major spliceosome, offering unique targets for study.
• Mutations in RNU4ATAC, a minor spliceosome component, cause severe developmental disorders such as MOPD I.
• U12-type splicing is conserved across eukaryotes, including plants where it affects development.
• The abundance of minor snRNPs is not limiting for U12-type splicing, suggesting complex regulation.
• Cryo-EM structures of the human minor spliceosome enable structure-based interpretation of disease variants.
• U12-type introns are evolutionarily dynamic, with lineage-specific gains and losses.
• Insect U12-type introns show unique features that inform comparative genomics.
• Studying U12-type splicing requires specialized experimental models and methods.
• The minor spliceosome is a potential therapeutic target for diseases caused by splicing defects.
What Happens During U12-type spliceosomal complex?
Recognition of U12-type introns
In simple terms: The minor spliceosome first finds and binds to rare introns that have unusual sequences at their ends.
The U12-type spliceosome recognizes introns with atypical AT-AC terminal dinucleotides and other non-canonical splice site signals. The entire splice site signal, not just the terminal dinucleotides, determines which spliceosome is used. The U11 and U12 snRNPs base-pair with the 5' splice site and branch site, respectively, initiating assembly.
Assembly of the minor spliceosome
In simple terms: Multiple small RNA-protein complexes come together step by step to form the active splicing machine.
The minor spliceosome is assembled from U11, U12, U4atac, U6atac, and U5 snRNPs. Cryo-EM structures of the fully assembled human minor spliceosome reveal the stepwise recruitment of these components and the conformational changes required for catalysis. The activated minor spliceosome structure shows how the catalytic core is organized.
Catalysis and intron excision
In simple terms: The assembled machine cuts out the intron and joins the two exons together.
The U12-type spliceosome catalyzes two transesterification reactions that excise the intron and ligate the exons. The catalytic core is formed by U6atac and U12 snRNAs, similar to the major spliceosome. Structural studies have captured the pre-catalytic and catalytic states, providing mechanistic insights.
Regulation of U12-type splicing
In simple terms: The cell controls when and how efficiently these rare introns are removed.
The abundance of minor snRNPs is not limiting for U12-type splicing, indicating that other factors regulate this process. In plants, the U11/U12-31K protein acts as an RNA chaperone to facilitate U12 intron splicing and affects development. Evolutionary studies show that U12-type introns are dynamically gained and lost across lineages.
Key Genes Involved in GO:0005689 U12-type spliceosomal complex
The following genes and snRNA components are core to the U12-type spliceosomal complex and are frequently studied in research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNU11 | U11 snRNA; base-pairs with 5' splice site | Essential for minor spliceosome assembly |
| RNU12 | U12 snRNA; base-pairs with branch site | Catalytic core component |
| RNU4ATAC | U4atac snRNA; minor spliceosome-specific | Mutations cause MOPD I |
| RNU6ATAC | U6atac snRNA; catalytic core | Required for catalysis |
| RNU5 | U5 snRNA; shared with major spliceosome | Stabilizes exons for ligation |
| ZRSR2 | U11/U12 associated protein | Frequently mutated in myeloid malignancies |
| RNPC3 | U11/U12-65K protein | Component of minor spliceosome |
| U11/U12-31K | RNA chaperone in plants | Affects plant development |
| PRPF8 | U5 snRNP protein | Shared with major spliceosome |
| EFTUD2 | U5 snRNP GTPase | Required for splicing |
| SNRNP200 | U5 snRNP helicase | Splicing regulation |
| DDX46 | RNA helicase | Minor spliceosome assembly |
| DDX23 | RNA helicase | Spliceosome activation |
| SART1 | U4atac/U6atac snRNP protein | Minor spliceosome-specific |
| CRNKL1 | Minor spliceosome component | Assembly factor |
| RBM48 | Minor spliceosome protein | Associated with developmental disorders |
| CWC22 | Splicing factor | Exon junction complex deposition |
How Is U12-type spliceosomal complex Regulated?
The U12-type spliceosomal complex is regulated at multiple levels. The abundance of minor snRNPs is not limiting for U12-type splicing, suggesting that other factors control the efficiency and specificity of this process. In plants, the U11/U12-31K protein functions as an RNA chaperone to facilitate U12 intron splicing and affects plant development. Evolutionary dynamics of U12-type introns indicate that their presence and splicing are subject to lineage-specific regulation. Additionally, mutations in RNU4ATAC alter minor spliceosome function and cause developmental disorders, highlighting the importance of proper regulation.
U12-type spliceosomal complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNU4ATAC | MOPD I; developmental disorders | Patient-derived fibroblasts; CRISPR knock-in of patient mutations |
| ZRSR2 | Myeloid malignancies | Knockout in hematopoietic cell lines |
| U11/U12-31K | Plant development | Arabidopsis knockout and overexpression |
| RNU12 | Splicing defects | CRISPR knockout in human cell lines |
| RNU6ATAC | Splicing defects | CRISPR knockout in human cell lines |
Developmental disorders caused by RNU4ATAC mutations
Mutations in RNU4ATAC, a non-coding gene encoding the U4atac snRNA of the minor spliceosome, cause microcephalic osteodysplastic primordial dwarfism type I (MOPD I) and related developmental disorders. Clinical interpretation of these variants is critical for diagnosis and genetic counseling.
Cancer and splicing dysregulation
Components of the minor spliceosome, such as ZRSR2, are recurrently mutated in myeloid malignancies, linking U12-type splicing to cancer. Dysregulation of minor splicing can alter the expression of genes involved in cell cycle control and DNA repair.
Plant development and U12-type splicing
In Arabidopsis, the U11/U12-31K protein is involved in U12 intron splicing and affects plant development, demonstrating the importance of this complex beyond animals.
From U12-type spliceosomal complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of minor spliceosome loss on cell viability? | CRISPR knockout of RNU12 or RNU4ATAC in human cell lines |
| How do disease-associated mutations in RNU4ATAC affect splicing? | Point mutation knock-in using CRISPR in patient-derived cells |
| What is the role of U11/U12-31K in plant development? | Arabidopsis knockout and overexpression lines |
| How is the minor spliceosome assembled? | Tagged knock-in of core components for affinity purification |
| What genes are regulated by U12-type splicing? | RNA-seq after overexpression of minor spliceosome components |
| Can minor spliceosome components be targeted for cancer therapy? | CRISPR library screening in cancer cell lines |
How to Study the U12-type spliceosomal complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Splicing efficiency of U12-type introns | Global analysis of minor splicing |
| Cryo-EM | 3D structure of spliceosomal complexes | Mechanistic studies |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identifying minor spliceosome dependencies |
| In vitro splicing | Catalytic activity of the spliceosome | Biochemical characterization |
| CLIP-seq | RNA binding sites of splicing factors | Mapping interactions |
| Proteomics | Protein composition of spliceosomal complexes | Identifying new components |
| qRT-PCR | Expression of specific spliced isoforms | Validation of splicing changes |
| Fluorescence microscopy | Localization of spliceosomal components | Cellular imaging |
RNA-seq and splicing analysis
RNA sequencing followed by bioinformatics analysis can identify U12-type introns and quantify their splicing efficiency. This method is essential for studying the impact of minor spliceosome perturbations.
Cryo-electron microscopy
Cryo-EM has been used to determine the structures of the fully assembled and activated human minor spliceosome, revealing molecular details of U12-type intron recognition and catalysis.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes required for U12-type splicing and uncover synthetic lethal interactions with minor spliceosome components.
Biochemical assays
In vitro splicing assays using nuclear extracts can measure the efficiency of U12-type intron removal and the requirement for specific snRNPs.
How CRISPR Can Be Used to Study GO:0005689 U12-type spliceosomal complex
Knockout
CRISPR knockout of minor spliceosome components such as RNU12 or RNU4ATAC can be used to study their essentiality and the consequences of U12-type splicing loss.
Point Mutation
Point mutations identified in patients, such as those in RNU4ATAC, can be introduced into cell lines using CRISPR to model developmental disorders and assess splicing defects.
Knock-in
Knock-in of tagged versions of minor spliceosome proteins allows for affinity purification and proteomic analysis of the complex.
Overexpression
Overexpression of minor spliceosome components or associated factors can be used to study their effects on U12-type splicing and cellular phenotypes.
How EDITGENE Supports U12-type spliceosomal complex Research
Researchers studying U12-type spliceosomal complex-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for U12-type spliceosomal complex research.
Frequently Asked Questions About U12-type spliceosomal complex
What is the U12-type spliceosomal complex?
It is a cellular machinery that removes rare introns with atypical AT-AC termini and other non-canonical splice sites from mRNA transcripts.
What genes are involved in the U12-type spliceosomal complex?
Key genes include RNU11, RNU12, RNU4ATAC, RNU6ATAC, and protein factors such as ZRSR2 and RNPC3.
What is the difference between the major and minor spliceosome?
The major spliceosome uses U1, U2, U4, and U6 snRNPs, while the minor spliceosome uses U11, U12, U4atac, and U6atac snRNPs.
What diseases are associated with U12-type splicing?
Mutations in RNU4ATAC cause MOPD I, and other components are linked to cancer and developmental disorders.
How can I study U12-type splicing in the lab?
Methods include RNA-seq, cryo-EM, CRISPR knockout, and in vitro splicing assays.
What is the role of RNU4ATAC?
RNU4ATAC encodes the U4atac snRNA, which is essential for minor spliceosome assembly and catalysis.
Are U12-type introns conserved?
Yes, U12-type introns are evolutionarily conserved but rare, and their presence varies across lineages.
What is the structure of the human minor spliceosome?
Cryo-EM structures have revealed the fully assembled and activated states of the human minor spliceosome.
Can CRISPR be used to model U12-type splicing diseases?
Yes, CRISPR knockout and knock-in can model mutations in minor spliceosome components.
What services does EDITGENE offer for U12-type spliceosome research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
The U12-type spliceosomal complex (GO:0005689) is a specialized molecular machine essential for the removal of rare non-canonical introns. Its unique composition and mechanism distinguish it from the major spliceosome, and its dysfunction is linked to severe developmental disorders and cancer. Continued research using advanced structural and genetic tools will further illuminate its roles in health and disease.
References
- 1. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 2. Janice J et al.. 2012. U12-type spliceosomal introns of Insecta.. Int J Biol Sci 8(3):344-52 PMID: 22393306
- 3. Lin CF et al.. 2010. Evolutionary dynamics of U12-type spliceosomal introns.. BMC Evol Biol 10:47 PMID: 20163699
- 4. Bai R et al.. 2021. Structure of the activated human minor spliceosome.. Science 371(6535) PMID: 33509932
- 5. Sharp PA et al.. 1997. Classification of introns: U2-type or U12-type.. Cell 91(7):875-9 PMID: 9428511
- 6. Benoit-Pilven C et al.. 2020. Clinical interpretation of variants identified in RNU4ATAC, a non-coding spliceosomal gene.. PLoS One 15(7):e0235655 PMID: 32628740
- 7. Kim WY et al.. 2010. The Arabidopsis U12-type spliceosomal protein U11/U12-31K is involved in U12 intron splicing via RNA chaperone activity and affects plant development.. Plant Cell 22(12):3951-62 PMID: 21148817
- 8. Pessa HK et al.. 2006. The abundance of the spliceosomal snRNPs is not limiting the splicing of U12-type introns.. RNA 12(10):1883-92 PMID: 16957280
